婴儿血管瘤
医学
皮肤病科
博莱霉素
血管瘤
不利影响
软组织
药品
外科
内科学
药理学
化疗
作者
Shize Lei,Qingmei Shi,Xingfan Chen,Shaorong Lei
出处
期刊:Journal of Chinese Physician
日期:2018-08-20
卷期号:20 (8): 1278-1280
标识
DOI:10.3760/cma.j.issn.1008-1372.2018.08.051
摘要
This article summarizes the pharmacological treatment of infantile hemangioma in soft tissue. We aim to review the literature and summarize the mechanisms, methods, efficiency and adverse reactions of beta blockers, glucocorticoids, bleomycin and imiquimott, and to analyze the rational options. Beta blockers, as oral and external use, have high efficiency and few side effects, and can be used as a first-line medication for infantile hemangiomas. Imiquimod external use and topical glucocorticoid and bleomycin injection have good efficacy and potential adverse reactions. They can be used as an alternative treatment for infantile hemangioma.
Key words:
Hemangioma/DT; Skin neoplasms/DT; Infant; Review
科研通智能强力驱动
Strongly Powered by AbleSci AI